Showing 1 - 11 results of 11 for search 'Lingzhi Yan', query time: 0.05s
Refine Results
-
1
Research Progress of Lateral Flow Immunoassay in Food Safety by Lingzhi YAN
Published 2022-02-01
Article -
2
Research Progress of Signal Amplification Strategies in Immunochromatographic Test Strip by Lingzhi YAN
Published 2022-06-01
Article -
3
-
4
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment by Shiyuan Zhou, Yingying Zhai, Lingzhi Yan, Xiaolan Shi, Jingjing Shang, Depei Wu, Chengcheng Fu, Song Jin
Published 2023-09-01
Article -
5
-
6
The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients by Hongying You, Hongying You, Song Jin, Song Jin, Chunxiao Wu, Chunxiao Wu, Qingqing Wang, Qingqing Wang, Shuang Yan, Shuang Yan, Weiqin Yao, Weiqin Yao, Xiaolan Shi, Xiaolan Shi, Jingjing Shang, Jingjing Shang, Lingzhi Yan, Lingzhi Yan, Ying Yao, Jing Wang, Panfeng Wang, Jinlan Pan, Jinlan Pan, Depei Wu, Depei Wu, Chengcheng Fu, Chengcheng Fu
Published 2022-10-01
Article -
7
The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients by Weiqin Yao, Weiqin Yao, Haifei Yang, Haifei Yang, Hongying You, Hongying You, Jingjing Shang, Jingjing Shang, Yingying Zhai, Yingying Zhai, Zhi Yan, Zhi Yan, Shuang Yan, Shuang Yan, Xiaolan Shi, Xiaolan Shi, Ying Yao, Jing Wang, Panfeng Wang, Yun Xu, Song Jin, Song Jin, Lingzhi Yan, Lingzhi Yan, Depei Wu, Depei Wu, Chengcheng Fu, Chengcheng Fu
Published 2023-09-01
Article -
8
Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma by Mo Zhou, Yan Chen, Yanlei Gong, Mingqing Zhu, Jiannong Cen, Jinlan Pan, Lingzhi Yan, Jingjing Shang, Song Jin, Xiaolan Shi, Weiqin Yao, Shuang Yan, Depei Wu, Suning Chen, Chengcheng Fu, Li Yao
Published 2024-03-01
Article -
9
Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma by Lingzhi Yan, Su Qu, Jingjing Shang, Xiaolan Shi, Liqing Kang, Nan Xu, Mingqing Zhu, Jin Zhou, Song Jin, Weiqin Yao, Ying Yao, Guanghua Chen, Huirong Chang, Xiaming Zhu, Lei Yu, Depei Wu, Chengcheng Fu
Published 2021-01-01
Article -
10
Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells by Jingwen Tan, Yujie Jia, Meixia Zhou, Chengcheng Fu, Israth Jahan Tuhin, Jing Ye, Masuma Akter Monty, Nan Xu, Liqing Kang, Minghao Li, Jiaqi Shao, Xiaoyan Fang, Hongjia Zhu, Lingzhi Yan, Changju Qu, Shengli Xue, Zhengming Jin, Suning Chen, Haiwen Huang, Yang Xu, Jia Chen, Miao Miao, Xiaowen Tang, Caixia Li, Zhiqiang Yan, Depei Wu, Lei Yu
Published 2022-04-01
Article -
11
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placeb... by Zhongjun Xia, Yun Leng, Baijun Fang, Yang Liang, Wei Li, Chengcheng Fu, Linhua Yang, Xiaoyan Ke, Hua Jiang, Jianyu Weng, Li Liu, Yaozhong Zhao, Xuejun Zhang, Zhongxia Huang, Aichun Liu, Qingzhi Shi, Yuhuan Gao, Xiequn Chen, Ling Pan, Zhen Cai, Zhao Wang, Yafei Wang, Yaqun Fan, Ming Hou, Yigai Ma, Jianda Hu, Jing Liu, Jianfeng Zhou, Xiaohong Zhang, Haitao Meng, Xuzhang Lu, Fei Li, Hanyun Ren, Bintao Huang, Zonghong Shao, Hebing Zhou, Yu Hu, Shifang Yang, Xiangjun Zheng, Peng Wei, Hongyan Pang, Wei Yu, Yuzhang Liu, Sujun Gao, Lingzhi Yan, Yanping Ma, Hongmei Jing, Juan Du, Wei Ling, Jingyi Zhang, Weiwei Sui, Fuxu Wang, Xin Li, Wenming Chen
Published 2023-10-01
Article